ΰÒײ©

  •  Î°Òײ©Ê×Ò³
  •  ½ÌѧÏîÄ¿
    ±¾¿Æ ѧÊõ˶²© MBA EMBA ¸ß²ãÖÎÀí½ÌÓý »á¼Æ˶ʿ ½ðÈÚ˶ʿ ÉÌÒµÆÊÎö˶ʿ Êý×Ö½ÌÓý ¿Î³ÌÍƼö
  •  ±±´óÖ÷Ò³
  •  Óû§µÇ¼
    ½ÌÖ°Ô±µÇ¼ ѧÉúµÇ¼ ΰÒײ©ÓÊÏä
  •  ½ÌÔ±ÕÐƸ  ¾èÔù
English
ΰÒײ©(ÖйúÇø)¹Ù·½ÍøÕ¾
ΰÒײ©(ÖйúÇø)¹Ù·½ÍøÕ¾

LIGHT UPרÀ¸

ÕÅÀÚ £ºÒ½Ñ§²©Ê¿µÄΰÒײ©MBA֮·

ʱ¼ä£º2020-09-14


ΰÒײ©(ÖйúÇø)¹Ù·½ÍøÕ¾

ÕÅÀÚ

ÉîÛÚÌì˸ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾¶­Ê³¤

ΰÒײ©MBA2017¼¶ÔÚÖ°°à


±àÕßµ¼Óï

Äõ½ÕÅÀÚ¼òÀúµÄʱ¼ä£¬±»ºóÃ渽ÉϵĽÒÏþÎÄÏ×¼°Ñо¿ÀÖ³ÉÏÅÁËÒ»Ìø¡£Ì¹³ÏµÄ˵£¬²¢Ã»Ïëµ½MBAµÄѧÉú»áÓÐÔÆÔƷḻµÄ¡¢´¿´âµÄѧÊõÐÔÑо¿Ð§¹û¡£Ò»Ê±ºÃÆæÐÄÖèÆð£ºÎªÊ²Ã´ÕâÑùÅä¾°µÄҽѧÉúҪѡÔñ±±´óΰÒײ©MBAÄØ£¿ËûÓÐ×ÅÔõÑùµÄÀíÏëÓë¹ÊÊ£¿ÈÃÎÒÃÇÒ»ÆðÀ´½ÒÏþ°É~

01

ÄÜ·ñÏÈΪ¸÷È˼òÆÓÏÈÈÝÒ»ÏÂ×Ô¼º£¿

ÎÒ³öÉúÓÚÒ½Éú¼ÒÍ¥£¬Ò»¾­ÔÚÉîÛÚÊжùͯҽԺ´Óʶù¿ÆÁÙ´²ÊÂÇ飬2008ÄêÓÚÏã¸ÛÖÐÎÄ´óѧȡµÃ²©Ê¿Ñ§Î»ºó½øÈ뻪´ó»ùÒò´ÓÊ»ùÒò×éѧÊÖÒÕµÄÁÙ´²×ª»¯ºÍÍƹ㣬֮ºóÔÚ¸´ÐÇÆìϵÄÑÇÄÜÉúÎï´ÓÊÂҽѧºÍBDÊÂÇé¡£2018Ä꣬ÎÒ¿ª°ìÁËÉîÛÚÌì˸ÉúÎï¿Æ¼¼ÓÐÏÞ¹«Ë¾£¬×¨×¢¾ÙÐÐÖ×ÁöÒºÌå»î¼ìÊÖÒÕµÄÑз¢¡¢×ª»¯ºÍÍƹã¡£

*ÕÅÀÚÑо¿Ïà¹Ø¼Í¼

Ó¢ÎIJ¿·Ö

[1] Qunxian Rao*, Qian Zhang*, Chunhong Zheng, Wenjun Dai,

Bingzhong Zhang, Cristian Ionescu-Zanetti,Zhongqiu Lin, Lei Zhang. Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system. Int J Clin Exp Pathol 2017;10(9):9599-9606.

[2] Zhang L, Tang J, Haines CJ, Feng H, Teng X, Han Y. RA induces differentiation of multipotent P19 cells towards male germ cell. In Vitro Cell Dev Biol Anim. 2015. 51(1): 85-91.

[3] Sun L*, Zhang L*, Zhou J, et al. Noninvasive prenatal testing for fetal trisomy 9 mosaicism by maternal plasma DNA sequencing[J]. Case Reports in Perinatal Medicine, 2015, 4(1): 37-40. (*contribute equally as first authors)

[5] Zhang L, Tang J, Haines CJ, et al. c-kit expression profile and regulatory factors during spermatogonial stem cell differentiation. BMC Dev Biol, 2013,13(1):38.

[6] Zhang L, Tang J, Haines CJ, Feng HL, Lai L, Teng X, Han Y. c-kit and its related genes in spermatogonial differentiation. Spermatogenesis, 2011,1(3):186-194.

[7] Choi H, Lau TK, Jiang FM, Chan MK, Zhang HY, Lo PS, Chen F, Zhang L, Wang W. Fetal aneuploidy screening by maternal plasma DNA sequencing: 'False positive' due to confined placental mosaicism. Prenat Diagn, 2013 Feb;33(2):198-200

[8] Chen S, Ge H, Wang X, Pan X, Yao X, Li X, Zhang C, Chen F, Jiang F, Li P, Jiang H, Zheng H, Zhang L, Wang W, Li S, Wang J, Yang H, Li Y, Zhang X. Haplotype-assisted accurate noninvasive fetal whole genome recovery through maternal plasma sequencing. Genome Med. 2013. 5(2): 18.

[9] Chen S, Lau TK, Zhang C, Xu C, Xu Z, Hu P, Xu J, Huang H, Pan L, Jiang F, Chen F, Pan X, Xie W, Liu P, Li X, Zhang L, Li S, Li Y, Xu X, Wang W, Wang J, Jiang H, Zhang X. A method for noninvasive detection of fetal large deletions/duplications by low coverage massively parallel sequencing. Prenat Diagn. 2013. 33(6): 584-90.

[10] Yao H, Zhang L, Zhang H, Jiang F, Hu H, Chen F, Jiang H, Mu F, Zhao L, Liang Z, Wang W. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn, 2012,32(11):1114-6.

[11] Chan KY, Xiang P, Zhou L, Li K, Ng PC, Wang CC,Zhang L, Deng HY, Pong NH, Zhao H, Chan WY, Sung RY. Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks. Eur J Heart Fail, 2011,13(4):366-76.

[12] Xiang P, Deng HY, Li K, Huang GY, Chen Y, Tu L, Ng PC, Pong NH, Zhao H, Zhang L, Sung RY. Dexrazoxane protects against doxorubicin-induced cardiomyopathy: upregulation of Akt and Erk phosphorylation in a rat model. Cancer Chemother Pharmacol, 2009,63(2):343-9.

ÖÐÎIJ¿·Ö

[1] ÕÅÀÚ, ÓÚ½à. ¶ùͯ¼±ÐÔ°×Ѫ²¡¼°¶ñÐÔÁÜ°ÍÁöµÄ°ÐÏòÖÎÁÆ. ÖйúÑ­Ö¤¶ù¿ÆÔÓÖ¾, 2006,1(3):215-222.

[2] ÕÅÀÚ, ÓÚ½à, Īæ­, µÈ. Fn¡¢TPO»ùÒòÐÞÊζÔÈ˹ÇËè¼ä³äÖʸÉϸ°ûµÄÓ°Ïì. ÖлªÑªÒºÑ§ÔÓÖ¾, 2007,28(12):832-836.

[3] ÕÅÀÚ, ÓÚ½à, Īæ­, µÈ. FN-TPO»ùÒòÐÞÊεĹÇËè¼ä³äÖʸÉϸ°ûÖ§³ÖÆêѪÔìѪ¸Éϸ°ûÖ²ÈëµÄʵÑéÑо¿. ÖйúÊäѪÔÓÖ¾, 2009,(02):94-98.

[4] ÕÅÀÚ£¬ÍõÍþ. ÎÞ´´²úÇ°»ùÒò¼ì²âÌ¥¶ùȾɫÌå·ÇÕû±¶ÌåÊÖÒÕÑо¿¼°Ó¦ÓÃÏ£Íû. Öйú²úÇ°Õï¶ÏÔÓÖ¾£¬2012,4(3):32-40.

[5] ÓÚ½à, ÕÅÀÚ, Īæ­, µÈ. Äæת¼²¡¶¾ÔØÌå½éµ¼Fn-TPO»ùÒòÐÞÊÎÈ˹ÇËè¼ä³äÖʸÉϸ°û. µÚÈý¾üÒ½´óѧѧ±¨, 2006,28(24):2396-2399.

[6] Īæ­, ÓÚ½à, ÑîĬ, ÀîÖ¾¹â, Àî¹ðϼ, ÕÅÀÚ. µ±¹é¶àÌÇÓëѪС°åÔ´ÐÔÉú³¤Òò×Ó¡¢ÑªÐ¡°åÌìÉúËضԾ޺Ëϸ°ûÔìѪӰÏìµÄ½ÏÁ¿Ñо¿. Öлª¶ù¿ÆÔÓÖ¾. 2008. 46(1): 45-48.

[7] ÎâÑÞ, ÓÚ½à, ÕÅÀÚ£¬µÈ. ÔÙÉúÕÏ°­ÐÔѪÐ黼¶ù¹ÇËè¼ä³äÖʸÉϸ°ûÌåÍâÔìѪ֧³Ö×÷ÓõÄÑо¿. Öйú½ñÊÀ¶ù¿ÆÔÓÖ¾. 2008. 10 (4): 455-459.

[8] ÎâÑÞ, ÓÚ½à, ÕÅÀÚµÈ. ÔÙÉúÕÏ°­ÐÔѪÐ黼¶ù¹ÇËè¼ä³äÖʸÉϸ°ûÃâÒßµ÷Àí×÷ÓõÄÑо¿. ÖйúÊÊÓöù¿ÆÔÓÖ¾. 2009. (10): 786-790.

[9] ÎâÑÞ, ÓÚ½à, ÕÅÀÚ, µÈ. ÌØ·¢ÐÔѪС°åïÔÌ­ÐÔ×Ïñ°»¼¶ù¹ÇËèMSC TGF-¦Â1ºÍHGFµÄ±í´ï¼°¶ÔÃâÒߵĵ÷Àí×÷ÓõÄÑо¿. ÖØÇìÒ½¿Æ´óѧѧ±¨, 2009,34(3):260-264.

[10] Ò¦ÐãÔÆ, ÕÅÓåÃÀ, ÇØÝè×Ó£¬²ýÊ¢£¬×ÞÁÕ£¬³ÂÊËƽ£¬ÕÅÀÚ£¬Ð»Ü磬ÖÓÏþÜ¿. ÖØÇìÊкº×å¶ùͯ¦Â-µØÖк£ÑªÐéµÄ·Ö×ÓÊ¢Ðв¡Ñ§Ñо¿. Öлª¶ù¿ÆÔÓÖ¾, 2013,51(7):518-522.

[11] ÔøÔÆ, ·ë´ó·É, ÕÅÀÚ, µÈ. ÏßÁ£ÌåMT-RNR1»ùÒòÍ»±äÓëÒ©ÎïÐÔÁû. ÌýÁ¦Ñ§¼°ÑÔÓï¼²²¡ÔÓÖ¾, 2013,(04):428-430.

[12] ÓÚ½à, ÏÜÓ¨, Ò¦ÐãÔÆ£¬Ð¤½£ÎÄ£¬Áõº£Ñ࣬³ÂÊËƽ£¬ÕÅÀÚ£¬ÕÅÓåÃÀ£¬ÇØÝè×Ó. ÖØÇìÊÐѧÁäÇ°¶ùͯ¦ÁµØÖк£ÑªÐéµÄ·Ö×ÓÊ¢Ðв¡Ñ§Ñо¿. ÖлªÑªÒºÑ§ÔÓÖ¾. 2014. 35(5): 419-423.

[13] Ðí¾ü, ҶСÀÚ, ³ÂÊç·É£¬Ö£ÖÜÊý£¬ÉÛС·É£¬ËÕÈʽÜ£¬ÕÅÀÚ£¬ÔøÔÆ£¬Ê·²¨Äþ. ÏÈÌìÐÔ·Ç×ÛºÏÕ÷ÐÔ¶úÁû»¼Õß100Àý³£¼û¶úÁû»ùÒòÆÊÎö. ÖйúÑÛ¶ú±Çºí¿ÆÔÓÖ¾. 2014. (03): 184-186.

[14] ÕÅÀÚ, »Æ»ÛÁá, Ñî°º, Ñî°º, Ö£´ººì, ÖìÓñ»ª, ÁõËÉ÷ë, ÀîÓ¡Êç. ÃâÒß´ÅÖé·¨ÒõÐÔ¸»¼¯Ñ­»·Ö×Áöϸ°ûÒªÁìµÄ½¨Éè. Ä¥Á·Ò½Ñ§. 2018,33 (8): 770-771.

Ö÷³Ö»ò¼ÓÈë¿ÎÌâ

[1] ÉîÛÚҺ̬»î¼ìÖ×Áö¸öÐÔ»¯Õï¶ÏÊÖÒÕ¹«¹²Ð§ÀÍƽ̨£¨Éî·¢¸Ä[2016] 887ºÅÎļþ£©£¬ÉîÛÚÊÐÉú³¤Ë¢ÐÂίսÂÔÐÔÐÂÐ˹¤ÒµºÍδÀ´¹¤ÒµÉú³¤×¨Ïî×ʽð£¬×ÊÖú¶î¶È500Íò£¬ÏîÄ¿ÈÏÕæÈË¡£

[2] Ñ­»·Ö×Áöϸ°û¼ì²âÊÖÒÕ¿ª·¢¼°ÔÚÂѳ²°©ÕïÁÆÖеÄÓ¦Óã¨KQCX2015033016451172£©£¬ÉîÛÚÊÐÍâÑó¸ßÌõÀíÈ˲ÅÁ¢Ò촴ҵרÏî×ʽð£¬×ÊÖú¶î¶È80Íò£¬ÏîÄ¿ÈÏÕæÈË¡£

[3] »ùÖÊϸ°ûºÍMSCµÄ»ùÒòÐÞÊζÔÔìѪϸ°ûÀ©Ôö¼°ÔìѪÖØÐÞµÄÓ°Ïì £¨30100095) ¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð×ÊÖúÏîÄ¿£¬×ÊÖú¶î¶È17Íò£¬¼ÓÈë¡£

[4] ¾«Ô­Ï¸°û·Ö½âµÄ»ùÒò±í´ï¼°µ÷¿Ø Hong Kong RGC grant (2140638)£¬×ÊÖú¶î¶È80Íò¸Û±Ò£¬¼ÓÈë¡£

02

ÔÚ¼òÀúÖп´µ½ÄãµÄѧÊõÑо¿Ð§¹ûÊ®·Ö·á¸»£¬ÄÜ·ñΪÎÒÃÇÏÈÈÝһϣ¿

ÔÚÒÑÍùµÄÊ®ÓàÄêÖУ¬ÎÒÖ÷ÒªÔÚ»ùÒòºÍϸ°ûÁ½¸öÆ«Ïò¾ÙÐÐÁËһЩ̽Ë÷£¬³Ðµ£»ò¼ÓÈë¹ý¹ú¼Ò¡¢Ê¡¡¢Êи÷¼¶¿Æ¼¼ÏîÄ¿Èô¸ÉÏÔÚº£ÄÚÍâÆÚ¿¯½ÒÏþÁ˶þÊ®ÓàƪѧÊõÂÛÎÄ£¬È¡µÃÁËÒ»µãЧ¹û£¬µ«ÈÔÐèÒª¼ÌÐøÆ𾢡£ÔÚ»ùÒòÁìÓò£¬ÎÒºÜÊÇÐÒÔ˵ÄÔÚÎÞ´´²úÇ°»ùÒò¼ì²â£¨NIPT£©ÏîÄ¿ÁÙ´²×ª»¯ºÍÍƹã×îÖ÷ÒªµÄ½×¶Î¼ÓÈëÆäÖв¢ÈÏÕæҽѧÊÂÎñ£¬Õâ¸öÏîÄ¿ÒѾ­ÔÚÈ«Çò¹æÄ£ÄÚ»ñµÃÆÕ±éÓ¦Ó㬹ØÓÚÔ¤·ÀÌÆÊÏ×ÛºÏÕ÷µÈÑÏÖسöÉúȱÏݵı¬·¢Æðµ½Á˺ܺõÄ×÷Óã¬ÎªÐí¶à¼ÒÍ¥×èÖ¹Á˱¯¾çµÄ±¬·¢£¬Í¬Ê±Ò²ÎªÈ«Éç»á½ÚÔ¼ÁË´ó×ÚµÄÒ½ÁÆ×ÊÔ´¡£Î´À´£¬Ð¡ÎÒ˽¼ÒÒÔΪÓиü´óҽѧ¼ÛÖµºÍÊг¡¿Õ¼äµÄÏîÄ¿Ó¦¸Ã³ö×Ôϸ°ûÁìÓò£¬ÓÉÓÚ²»¹ÜÊÇÄĸö·Ö×Ó²ãÃæµÄ¸Ä±ä×îÖÕ¶¼ÐèÒªÓ°Ïìϸ°ûµÄ¹¦Ð§¶øµ¼Ö¼²²¡±¬·¢¡£Î´À´ÈýÊ®Ä꣬Ëæ×ÅÎÒ¹úÀÏÁ仯µÄÒ»Ö±¼Ó¾çºÍÔ¤ÆÚÈ˾ùÊÙÃüµÄÒ»Ö±Ìá¸ß£¬ÒÔ°©Ö¢¡¢ÐÄÄÔѪ¹Ü¼²²¡ºÍÌÇÄò²¡Îª´ú±íµÄÂýÐÔ²¡µÄ·¢²¡ÂÊÒ»¶¨ÖðÄêÉý¸ß£¬¶øÈËÀà¶ÔÕâЩ¼²²¡µÄÊìϤ»¹²»Í¸³¹£¬ÒÔÊÇ»ùÓÚϸ°û²ãÃæµÄÑо¿ºÍҽѧӦÓÃÒ»¶¨´óÓпÉΪ¡£

03

ÄãÔÚÊÂÇéÇ°ÆÚÒ»Ö±óÆ־ѧÊõÑо¿ÒÔ¼°ÁÙ´²Ò½Ñ§£¬µ«½ü¼¸ÄêÏòÉÌÒµ»¯µÄÆ«Ïò¾ÙÐÐÁËת±ä£¬ÄÜ·ñΪÎÒÃÇ·ÖÏíÒ»ÏÂÄãµÄÆðµã£¿

»òÐíÊÇÓÉÓÚҽѧÅä¾°µÄÉíÊÀ£¬Ïà±È»ù´¡Ñо¿£¬ÎÒ¸üϲ»¶Ó¦ÓÃÑо¿»òÕßת»¯Ñо¿¡£ÎÒµÄÈËÉúÔ¶¾°£¬ÊÇÖúÁ¦ÁÙ´²¡¢Ô츣¹«¹²£¬½«È«Çò×îÏȽøµÄ¿ÆÑÐЧ¹ûת»¯³ÉÁÙ´²¿ÉÓõÄÊÖÒպͲúÆ·£¬Íƶ¯ÎÒ¹ú¿µ½¡ÊÂÒµÉú³¤¡£¶àÄêÇ°£¬ÔÚÎÒ¸Õ¸Õ½øÈëÒ½Ôº£¬×îÏÈ´ÓÊÂÁÙ´²ÊÂÇéµÄʱ¼ä£¬ÎÒÔøÔÚÐÄÖиø×Ô¼ºËã¹ýÒ»±Ê¼òÆÓµÄÕÊ£º×÷ΪһÃûÁÙ´²Ò½Éú£¬ÈôÊÇÎÒÌìÌìЧÀÍÒ»°Ùλ»¼Õߣ¬Ò»ÄêËêÇéÈý°ÙÌ죬ÄÇô×î¶àЧÀÍÈýÍòÃû»¼Õߣ¬ÍËÐÝÇ°ÊÂÇéÈýÊ®Ä꣬×î¶à¿ÉÒÔЧÀ;ÅÊ®ÍòÃû»¼Õߣ»¶øÈôÊÇÎÒת»¯ÀÖ³ÉÒ»¸öÏîÄ¿£¬Ò»ÄêЧÀ͵Ļ¼ÕßÊýÄ¿¾ÍÔ¶Ô¶²»Ö¹¾ÅÊ®Íò¡£Ä¿µÄÒѾ­¶¨Ï£¬Ê£ÏµľÍÊÇÔõÑùʵÏÖ¡£È»¶ø£¬×öѧÊõºÍ×ö²úÆ·£¨ÉÌÒµ£©ÊÇÁ½ÂëÊ£¬¶ÔÎÒµÄÌôÕ½Ò²ÊÇÈ«·½Î»µÄ£¬È»¶øÎÞÂÛÓöµ½Ê²Ã´ÑùµÄÄÑÌ⣬˭ÈËÎôʱ¿´ÆðÀ´ÓÐЩÖÉ×ÓµÄËãÊõÌâÕâô¶àÄêÀ´Ò»Ö±Íƶ¯ÎÒһֱǰ½ø£¬²»´ïÄ¿µÄ²»ÈöÊÖ£¡

ΰÒײ©(ÖйúÇø)¹Ù·½ÍøÕ¾

04

ÄãÒÔΪÄãµÄÖ°Òµ×·ÇóÊÇ·ñÊܵ½±±´óµÄ¼Ò¹úÇ黳ӰÏ죿Ϊʲô×îÖÕÑ¡ÔñÁË´´Òµ£¿

±±´óµÄÏȽøÃÇΪÖлªÃñ×åµÄΰ´óÔÙÆð×ö³öÁ˲»¿ÉÏûÊŵÄТ˳£¬ËûÃÇÊÇÎÒ½ñÉúѧϰµÄ¿¬Ä£¡£´´Òµ¹ØÓÚÎÒÀ´Ëµ²»ÊÇÄ¿µÄ£¬ËüÖ»ÊÇÒ»¸öÀú³Ì¡¢Ò»ÖÖÄ¥Á·¡£Ñ¡Ôñ´´ÒµÊÇΪÁ˸üºÃµÄÍƶ¯ÏîÄ¿µÄÏ£Íû£¬Ï£Íûͨ¹ýÈô¸ÉÄ겻иµÄÆð¾¢£¬Äܹ»ÔÚ»ù´¡Ñо¿ÓëÁÙ´²Ò½Ñ§¼ä¼ÜÉèÆðÒ»×ùÇÅÁº£¬½«ÓÅÒìµÄ»ù´¡Ñо¿Ð§¹û¿ìËÙת»¯³ÉÉú²úÁ¦¡£

05

ͨË×ÈËÒ»Ñùƽ³£ÊÇÖð¼¶ÏòÉÏÐÞϰѧ룬¶øÄãÔÚÍê³É²©Ê¿Ñ§Î»ºó£¬ÄæÁ÷¶øÐоͶÁMBA£¬ÄãΪʲô×öÕâÑùµÄÑ¡Ôñ£¿

ѧλÓÐÆéá«£¬µ«Ñ§Ï°ºÍ֪ʶûÓиßÏÂÖ®·Ö¡£ËäÈ»ÎÒÔÚҽѧÁìÓòѧϰ¡¢Ñо¿Á˶àÄ꣬Ҳ»ñµÃÁ˲©Ê¿Ñ§Î»£¬µ«Ê¼ÖÕÒÔΪ×Ô¼ºµÄ֪ʶÃ滹½ÏÁ¿Õ­£¬²»¿ÉÖª×ã×÷ΪһÃû´´ÒµÕßµÄÒªÇó¡£Òò´Ë£¬ÔÚÕýʽ̤ÉÏ´´ÒµÂ·Ö®Ç°£¬ÎÒÏ£ÍûÄÜϵͳµÄÏàʶ¹ØÓÚÆóÒµÔËÓªµÄÏà¹Ø֪ʶ£¬¶øMBAµÄ¿Î³ÌÉèÖÃÇ¡Ç¡ºÜºÃµÄÖª×ãÁËÎÒµÄÐèÇó£¬ÒÔÊǶÁMBA¶ÔÎÒÀ´Ëµ¾ÍÊÇÒ»ÖÖѧϰ·½·¨£¬²»±£´æ˳Á÷¡¢ÄæÁ÷¡£

06

´ÓÒ½Éú¡¢Ñ§ÕߵĽÇÉ«Çл»µ½ÉÌÈ˺ʹ´ÒµÕߣ¬ÆäÖÐÓöµ½¹ýÄÄЩÄÑÌâ»òÖÊÒÉÂð£¿

Ò½Éú¡¢Ñ§ÕßÓëÉÌÈË¡¢´´ÒµÕß¼äµÄ²î±ðÖØ´ó¡£Ò½Éú¡¢Ñ§ÕßµÄÊÂÇéÐÔ×ÓÖ÷ÒªÊÇÊÖÒÕÐÔÊÂÇ飬ÃæÁÙµÄÎÊÌâÒ²¶àÊǿ͹۵ġ¢È·¶¨ÐԵģ»¶øÉÌÈË¡¢´´ÒµÕßµÄÊÂÇéÐÔ×ÓÔ½·¢¶àÔª»¯£¬Ö÷¿Í¹Û¶¼ÓУ¬²»È·¶¨ÐԺܸß¡£Òò´Ë£¬´´ÒµÖ®³õ£¬ÓÉÏà¶ÔÈ·¶¨ÐÔµÄÊÂÇéת±äΪ¸ß¶È²»È·¶¨ÐÔµÄÊÂÇ飬¶ÔÎҵĹ¥»÷ºÜ´ó£¬ËùÐÒ¾­Óɵ÷½â£¬ÎÒÒѾ­Öð½¥Ë³Ó¦ÁËÕâÖÖÊÂÇé·½·¨¡£Ð¡ÎÒ˽¼ÒÒÔΪ£¬¹ØÓÚ´´ÒµÕßÀ´Ëµ×îÖ÷ÒªµÄÊÇÍŶӡ¢×ʽðºÍÐÄ̬£¬ÕâÈý¸ö·½ÃæÓÈÒÔÐÄ̬×îΪÖ÷Òª£¬¾ø´ó´ó¶¼´´ÒµÏîÄ¿¶¼ÊÇÔÚ×ÊÔ´ºÜÊÇÓÐÏÞµÄÇéÐÎÏÂͨ¹ýÆ´ÃüÆ𾢲ŻªÉú³¤ÆðÀ´µÄ£¬µ±ÀíÏëÔâÓöÏÖʵ£¬¼á³ÖÓÅÒìµÄÐÄ̬£¬²»Íü³õÐÄ£¬½«´óÄ¿µÄÆÊÎö³ÉÒ»¸ö¸ö½×¶ÎÐÔµÄСĿµÄ£¬²¢ÇÒÖð¸ö¸æ¿¢£¬ÏòÄ¿µÄÂõ½øµÄ³ÌÐòÀúÀ´¶¼²»ÅÂС¡£

07

±±´óΰÒײ©MBAµÄ¿Î³ÌÊÇ·ñ¸øÄãµÄÊÂÒµ´øÈ¥ÖúÁ¦£¿¶ÔÄãµÄÈËÉúÓÐʲôÆô·¢£¿

±±´óΰÒײ©MBA¿Î³Ì¸øÎÒµÄÊÂÒµ´øÀ´ºÜ´óÖúÁ¦¡£±±´óΰÒײ©ÖÎÀíѧԺÊǺ£ÄÚ×îÔ罨ÉèµÄÖÎÀíѧԺ֮һ£¬¡°´´Á¢ÖÎÀí֪ʶ£¬×÷ÓýÉ̽çÊ×ÄÔ£¬Íƶ¯Éç»áÇ°½ø¡±ÊÇΰÒײ©ÖÎÀíѧԺµÄʹÃü£¬Î°Òײ©MBA¿Î³Ì¾ùÓÉÓµÓвî±ðѧÊõÅä¾°ºÍÂÄÀú¡¢ÔÚ¹ú¼ÊÉÏÓнϸß×ÅÃû¶ÈµÄ½ÌÊÚÈνÌ¡£¿Î³ÌÄÚÈݼÈÓи»ºñµÄѧÊõÀíÂÛ֪ʶ£¬ÓÖÓдó×Úʵ²ÙÐԵݸÀý£¬ÀíÂÛºÍʵ¼ù͎ᣬÈÃÎÒ»ñµÃÁË´ó×ÚҽѧרҵÒÔÍâµÄ¶Ô´´ÒµÓÖÖÁ¹ØÖ÷ÒªµÄ֪ʶ¡£³ý¿ÎÌÃÉϵÄ֪ʶÍ⣬½ÌÊÚÃÇÕë¶ÔÏêϸµÄ´´ÒµÏîÄ¿»¹»á´Ó²î±ðµÄ½Ç¶È¸ø³ö½¨ÒéÒÔ¼¿ÕÊÖú¶Ô½ÓÖÖÖÖ×ÊÔ´¡£ÁíÍ⣬±±´óΰÒײ©MBAͬÑâ¾ùÊÇÀ´×Ô¸÷Ðи÷ÒµµÄ¾«Ó¢£¬ÓëͬÑâÃǵĽ»Á÷Ò²¼«´óÁË̹µ´ÁËÎÒµÄ˼Ð÷£¬ÈÃÎÒ»ñÒæ·Ëdz¡£±ðµÄ£¬±±´óΰÒײ©MBAÉÐÓÐÒ쳣ǿʢµÄУÓÑȺ£¬¸»ºñµÄУÓÑÔ˶¯Í¬Ñù¸ø´¦ÓÚ´´ÒµÆ𲽽׶εÄÎÒ´øÀ´ºÜ´óÖúÁ¦¡£

08

´ó´ó¶¼MBAͬÑâµÄÅä¾°¶¼ÊǽðÈÚ¡¢IT»¥ÁªÍøÒÔ¼°ÆäËû¹¤ÒµÏà¹Ø£¬Äã×÷ΪÁÙ´²Ò½Ñ§ÕâÑùµÄѧÊõÐÔÅä¾°¼ÓÈëΰÒײ©MBA¸÷ÈËÍ¥ÒÔºó£¬ÓÐÔõÑùµÄ¹¥»÷¡¢ÊÕ»ñ¡¢¿ìÀÖ»òÄÑÌâÄØ£¿

̸²»Éϱ£´æ¹¥»÷ºÍÄÑÌ⣬µ«ÊÕ»ñºÜÊÇ´ó£¬Óë²î±ðÐÐÒµµÄͬÑâÒ»Æðѧϰ¡¢Ò»ÆðÌÖÂÛ£¬ÈÃÎÒÓú·¢ÊìϤµ½ÖªÊ¶µÄÖڶ࣬һСÎÒ˽¼ÒÔÙ²©Ñ§ËûËùÄÜÕÆÎÕµÄ֪ʶºÍÊÖÒÕÒ²ÓÐÒ»¶¨Ï޶ȣ¬Ö»ÓÐÓëÆäËûÓÅÒìµÄÈËÒ»Æð×é³ÉÍŶӡ¢Ï໥ÅäºÏ²Å»ªÈ¡µÃ¸ü´óµÄÀֳɡ£

ΰÒײ©(ÖйúÇø)¹Ù·½ÍøÕ¾

09

ÓÐʲô¼ÄÓïÏëË͸ø2020ÄêµÄÉêÇëÕßÂð£¿

½ö½ö»¨Á½Äêʱ¼ä£¬ÄÜÈÃÄã»ñÈ¡Ñ°³£Èô¸ÉÄê²Å»ª»ñµÃµÄ֪ʶºÍÊÖÒÕ£¬µ½±±´óΰÒײ©¶ÁMBAÒ»¶¨ÊÇÒ»±ÊºÜ»®ËãµÄͶ×Ê¡£

10

¿ìËٻظ²×îºóÒ»¸öÎÊÌ⣬ÈôÊÇÄãÒªÔÚÃìÎÞÈËÑ̵Ļĵº´ô7Ì죬ֻÄÜ´ø5¼þ¹¤¾ß£¬Äã»á´øʲô£¿

×ã¹»µÄʳÎï¡¢µ­Ë®¡¢Ò©Æ·£¬Çå¾²·À»¤¹¤¾ßºÍÌ«ÑôÄÜÎÀÐǵ绰¡£

±àÕß½áÓï

ÀíÏëÖ÷ÒåºÍ¼Ò¹úÇ黳£¬ÊDZ±´óѧ×ÓÓбðÓÚËûÈ˵ÄÌØÉ«Ö®Ò»£¬ÔÚ²¿·ÖÈËÑÛÖУ¬Õâ»òÐíÊÇÒ»ÖÖ¡°ÖÉ×Ó¡±¡£µ«ÎÒÐÅÍУ¬Ç¡Ç¡ÊÇÕâÑùµÄ¡°ÖÉ×Ó¡±£¬²Å»ªÈÃÕÅÀÚÔÚÒ½Éú¡¢Ñ§ÕßÓëÉÌÈË¡¢´´ÒµÕß¼äÕâÑù²î±ðÖØ´óµÄ½ÇÉ«Çл»Ö®¼ä¼á³Ö±¾Õ棬²»Íü³õÐÄ¡£Ã»ÓлªÃÀµÄ´ÇÔ壬ֻÓÐÖÊÆӵijÂÊö£¬ÕâÊÇËûµÄ¹ÊÊ£¬ÊÇÐí¶àÄ»ºóÊÂÇéÕߵĹÊÊ¡£


ΰÒײ©MBAÏîÄ¿

ΰÒײ©MBAÏîÄ¿ÖÂÁ¦ÓÚ×÷Óý¾ßÓÐÉç»áÔðÈθкÍÈ«ÇòÊÓÒ°µÄ¸ß¼¶ÖÎÀíÕßÓëδÀ´ÉÌÒµÊ×ÄÔ¡£Î°Òײ©ÖÎÀíѧԺMBAÏîÄ¿¼á³ÖÒÔ¡°´´Á¢ÖÎÀí֪ʶ£¬×÷ÓýÉ̽çÊ×ÄÔ£¬Íƶ¯Éç»áÇ°½ø¡±ÎªÊ¹Ãü£¬Æð¾¢´òÔ츻ÓÐÈËÎľ«ÉñµÄMBAÏîÄ¿£¬½èÖú±±´óÉîÖ¿µÄÈËÎÄÃØÎÅ¡¢ÏµÍ³¶øÁ¢ÒìµÄ¿Î³ÌÉèÖÃÒÔ¼°¸»ºñµÄÉç»áÔ˶¯£¬Ê¹Ñ§ÉúÏàʶǰÑØÉÌҵ֪ʶ£¬¾ß±¸¿çÎÄ»¯Ãô¸ÐÐÔÓëÈ˼ÊÏàͬÊÖÒÕ£¬³ÉΪ¾ßÓÐÔÚÖØ´óÇéÐÎÏÂÆÊÎö½â¾öÎÊÌâÄÜÁ¦µÄ¡¢ÓÂÓڼ縺δÀ´ÌôÕ½µÄÁ¢ÒìÐÍÈ˲Å¡£



·ÖÏí

010-62747288/62747299

±±¾©Êк£µíÇøÒúÍ԰·5ºÅΰÒײ©2ºÅÂ¥K01/K02MBAÏîÄ¿

?2017 ΰÒײ© °æȨËùÓÐ    ¾©ICP±¸05065075-1

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿